395 related articles for article (PubMed ID: 19651290)
21. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW
J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
[TBL] [Abstract][Full Text] [Related]
22. Epidermal growth factor receptor polymorphism and autosomal dominant polycystic kidney disease.
Magistroni R; Manfredini P; Furci L; Ligabue G; Martino C; Leonelli M; Scapoli C; Albertazzi A
J Nephrol; 2003; 16(1):110-5. PubMed ID: 12653106
[TBL] [Abstract][Full Text] [Related]
23. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.
Tao Y; Kim J; Schrier RW; Edelstein CL
J Am Soc Nephrol; 2005 Jan; 16(1):46-51. PubMed ID: 15563559
[TBL] [Abstract][Full Text] [Related]
24. Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).
Fischer DC; Jacoby U; Pape L; Ward CJ; Kuwertz-Broeking E; Renken C; Nizze H; Querfeld U; Rudolph B; Mueller-Wiefel DE; Bergmann C; Haffner D
Nephrol Dial Transplant; 2009 Jun; 24(6):1819-27. PubMed ID: 19176689
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis and loss of renal tissue in polycystic kidney diseases.
Woo D
N Engl J Med; 1995 Jul; 333(1):18-25. PubMed ID: 7776989
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic approach in autosomal dominant polycystic kidney disease.
Pei Y
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1108-14. PubMed ID: 17699332
[TBL] [Abstract][Full Text] [Related]
27. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of progression in autosomal dominant polycystic kidney disease.
Grantham JJ
Kidney Int Suppl; 1997 Dec; 63():S93-7. PubMed ID: 9407432
[TBL] [Abstract][Full Text] [Related]
29. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
Devuyst O
J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
[TBL] [Abstract][Full Text] [Related]
30. Autosomal-dominant polycystic kidney disease and kidney transplantation: experience of a single center.
Gonçalves S; Guerra J; Santana A; Abreu F; Mil-Homens C; Gomes da Costa A
Transplant Proc; 2009 Apr; 41(3):887-90. PubMed ID: 19376380
[TBL] [Abstract][Full Text] [Related]
31. [Heterozygosity loss and somatic mutations in type I and II dominant autosomal renal polycystic kidney disease: evidence of a recessive mechanism at a cell level in cystogenesis].
Pérez-Oller L; Torra R; Badenas C; San Millán JL; Darnell A
Nefrologia; 2000; 20(2):130-8. PubMed ID: 10853193
[TBL] [Abstract][Full Text] [Related]
32. Effect of Sirolimus on Native Total Kidney Volume After Transplantation in Patients with Autosomal Dominant Polycystic Kidney Disease: A Randomized Controlled Pilot Study.
Davis S; Gralla J; Chan L; Wiseman A; Edelstein CL
Transplant Proc; 2018 Jun; 50(5):1243-1248. PubMed ID: 29880342
[TBL] [Abstract][Full Text] [Related]
33. Retrospective analysis of factors affecting the progression of chronic renal failure in adult polycystic kidney disease.
Ahmed ER; Tashkandi MA; Nahrir S; Maulana A
Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):511-5. PubMed ID: 17186685
[TBL] [Abstract][Full Text] [Related]
34. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis.
Xu N; Glockner JF; Rossetti S; Babovich-Vuksanovic D; Harris PC; Torres VE
J Nephrol; 2006; 19(4):529-34. PubMed ID: 17048214
[TBL] [Abstract][Full Text] [Related]
35. Favorable graft survival in renal transplant recipients with polycystic kidney disease.
Johnston O; O'Kelly P; Donohue J; Walshe JJ; Little DM; Hickey D; Conlon PJ
Ren Fail; 2005; 27(3):309-14. PubMed ID: 15957548
[TBL] [Abstract][Full Text] [Related]
36. Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease.
Hoevenaren IA; Wester R; Schrier RW; McFann K; Doctor RB; Drenth JP; Everson GT
Liver Int; 2008 Feb; 28(2):264-70. PubMed ID: 17927714
[TBL] [Abstract][Full Text] [Related]
37. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease.
Paterson AD; Magistroni R; He N; Wang K; Johnson A; Fain PR; Dicks E; Parfrey P; St George-Hyslop P; Pei Y
J Am Soc Nephrol; 2005 Mar; 16(3):755-62. PubMed ID: 15677307
[TBL] [Abstract][Full Text] [Related]
38. Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.
Kanaan N; Goffin E; Pirson Y; Devuyst O; Hassoun Z
Am J Kidney Dis; 2010 May; 55(5):916-22. PubMed ID: 20189277
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous bilateral native nephrectomy and living donor renal transplantation are successful for polycystic kidney disease: the University of Maryland experience.
Kramer A; Sausville J; Haririan A; Bartlett S; Cooper M; Phelan M
J Urol; 2009 Feb; 181(2):724-8. PubMed ID: 19091353
[TBL] [Abstract][Full Text] [Related]
40. Selective, concurrent bilateral nephrectomies at renal transplantation for autosomal dominant polycystic kidney disease.
Wagner MD; Prather JC; Barry JM
J Urol; 2007 Jun; 177(6):2250-4; discussion 2254. PubMed ID: 17509331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
